292 related articles for article (PubMed ID: 9311667)
1. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.
Ebert B; Mikkelsen S; Thorkildsen C; Borgbjerg FM
Eur J Pharmacol; 1997 Aug; 333(1):99-104. PubMed ID: 9311667
[TBL] [Abstract][Full Text] [Related]
2. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord.
Ebert B; Andersen S; Krogsgaard-Larsen P
Neurosci Lett; 1995 Mar; 187(3):165-8. PubMed ID: 7624018
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of [3H]MK-801 binding in the rat spinal cord.
Souverbie F; Mo LL; Liu Y; von Euler G; Sundstr-om E
Eur J Pharmacol; 1996 Jul; 307(3):347-53. PubMed ID: 8836624
[TBL] [Abstract][Full Text] [Related]
4. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.
Sałat K; Siwek A; Starowicz G; Librowski T; Nowak G; Drabik U; Gajdosz R; Popik P
Neuropharmacology; 2015 Dec; 99():301-7. PubMed ID: 26240948
[TBL] [Abstract][Full Text] [Related]
6. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine.
Shimoyama M; Shimoyama N; Gorman AL; Elliott KJ; Inturrisi CE
Pain; 1999 May; 81(1-2):85-93. PubMed ID: 10353496
[TBL] [Abstract][Full Text] [Related]
7. No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries.
von Euler M; Li-Li M; Whittemore S; Seiger A; Sundström E
J Neurotrauma; 1997 Jan; 14(1):53-61. PubMed ID: 9048311
[TBL] [Abstract][Full Text] [Related]
8. Unique properties of [3H]MK-801 binding in membranes from the rat spinal cord.
Liu Y; Souverbie F; Sundström E; von Euler G
Brain Res; 1997 May; 757(2):167-75. PubMed ID: 9200745
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of N-methyl-D-aspartate receptors in spinal cord of rats with a chronic peripheral mononeuropathy.
Wei HB; Jakeman LB; Hunter JC; Bonhaus DW
Neuropharmacology; 1997; 36(11-12):1561-9. PubMed ID: 9517427
[TBL] [Abstract][Full Text] [Related]
10. Depression of NMDA-receptor-mediated segmental transmission by ketamine and ketoprofen, but not L-NAME, on the in vitro neonatal rat spinal cord preparation.
Lizarraga I; Chambers JP; Johnson CB
Brain Res; 2006 Jun; 1094(1):57-64. PubMed ID: 16716267
[TBL] [Abstract][Full Text] [Related]
11. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
[TBL] [Abstract][Full Text] [Related]
12. Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate.
Kovács KJ; Larson AA
Eur J Pharmacol; 1997 Apr; 324(1):117-23. PubMed ID: 9137921
[TBL] [Abstract][Full Text] [Related]
13. Polyamine and redox modulation of [3H]MK-801 binding to N-methyl-D-aspartate receptors in the spinal cord and cerebral cortex.
Sundström E; Mo LL
Pharmacol Toxicol; 2001 Jun; 88(6):342-8. PubMed ID: 11453375
[TBL] [Abstract][Full Text] [Related]
14. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists.
Nakai T; Milusheva E; Baranyi M; Uchihashi Y; Satoh T; Vizi ES
Eur J Pharmacol; 1999 Feb; 366(2-3):143-50. PubMed ID: 10082194
[TBL] [Abstract][Full Text] [Related]
15. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
Grant KA; Colombo G; Grant J; Rogawski MA
Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
[TBL] [Abstract][Full Text] [Related]
16. The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones.
Jones MW; McClean M; Parsons CG; Headley PM
Neuropharmacology; 2001 Jul; 41(1):50-61. PubMed ID: 11445185
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding.
Sharif NA; Nunes JL; Whiting RL
Neurochem Res; 1991 May; 16(5):563-9. PubMed ID: 1836546
[TBL] [Abstract][Full Text] [Related]
18. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
20. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
